EUIPO trademark

REZARQLO

RegisteredEUIPOWord markClass 5

"REZARQLO" is a word mark owned by Juno Therapeutics, Inc., filed at the EUIPO on April 1, 2026. It is registered and covers class 5 (Pharmaceuticals).

View Juno Therapeutics, Inc. portfolioGet this data via the API
Official EUIPO record
REZARQLO
Word mark as filed with the EUIPO
Status
Registered
Since July 26, 2026
Filed
April 1, 2026
Registered
July 26, 2026
Expires
April 1, 2036
Application no.
019341562
Registration no.
019341562
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns REZARQLO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Juno Therapeutics, Inc.

BMY

382 trademarks in the portfolioView company

Representative

FRKelly

Goods and services

What the mark covers

The products and services REZARQLO is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2026/141 Section B.1
  2. Bulletin 2026/071 Section A.1
FAQ

About REZARQLO

Who owns the trademark "REZARQLO"?

The EUIPO trademark "REZARQLO" (application 019341562) is owned by Juno Therapeutics, Inc.

What is the status of "REZARQLO"?

Its status at the EUIPO is: registered.

When was "REZARQLO" registered?

It was registered on July 26, 2026 and is due to expire on April 1, 2036.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull REZARQLO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d8b10-a8e5-758f-9c8a-7ca5a611df37
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d8b10-a8e5-758f-9c8a-7ca5a611df37",
  "object": "trademark",
  "mark_text": "REZARQLO",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "019341562",
  "filing_date": "2026-04-01",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Juno Therapeutics, Inc.",
      "entity_id": "ent_019ebb07-7485-715a-bb4f-5244d59e8f19"
    }
  ]
}